List view / Grid view

Toby Ferguson (Biogen)

 

article

Converging knowledge and technology to transform neuromuscular disease treatment

With the emergence of innovative therapeutic technologies and progress in…

19 December 2022 | By

With the emergence of innovative therapeutic technologies and progress in the genetic understanding of diseases, Biogen’s Toby Ferguson explains why it is a promising time for the development of therapies for neuromuscular conditions such as amyotrophic lateral sclerosis (ALS).